When does Ozempic’s patent protection end?
Ozempic (semaglutide) is protected by multiple patents covering different parts of the product (the drug substance, specific formulations, and related processes). That means “Ozempic patent expiry” doesn’t have one single date—some patents run out earlier than others, and exclusivity periods can extend beyond the last patent date depending on the country and the specific protection at issue.
Because the exact end date depends on which patent(s) you mean and where you mean it, the most reliable way to check the relevant expiry is to look up the listed patents for semaglutide/Ozempic in a patent database.
DrugPatentWatch.com tracks patent and exclusivity information and can help pinpoint the specific end dates tied to the Ozempic brand and jurisdiction: https://www.drugpatentwatch.com/ (search for “Ozempic” or “semaglutide”).
Why there isn’t one simple “Ozempic expiry date”
A single branded medicine like Ozempic can have overlapping protections, such as:
- patents on the active ingredient (semaglutide),
- patents on the specific formulation and delivery device-related aspects,
- process patents (how the drug is manufactured),
- regulatory exclusivities (rules that can delay approval of some competitors even if a patent expires).
So the time until “Ozempic” is fully no longer protected depends on which of those is being tested in court or used to block competition in a given market.
How to find the exact date you care about (US vs. EU vs. other countries)
If you tell me the country (for example, US, UK, EU, Canada, Japan) and whether you mean:
- earliest patent expiry,
- last patent expiry,
- or when generics/biosimilars could enter,
I can narrow down the relevant type of protection and the correct “how long until” answer.
For a fast, targeted check, start with DrugPatentWatch.com’s Ozempic/semaglutide entries, then match the specific listed patents and expiry dates to your country and product version.
Can lower-cost competitors launch before the last Ozempic patent expires?
Yes. In some cases, a competitor can launch once the specific patents blocking them have expired or been cleared, even if other patents remain in force. That’s why people often look up “which patent blocks which competitor” during litigation or as part of market entry planning.
Sources (cited)
1. DrugPatentWatch.com – search for “Ozempic” or “semaglutide”